Compare ADMA Biologics Inc (ADMA) vs Booz Allen Hamilton Holding Corporation (BAH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Booz Allen Hamilton Holding Corporation — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Booz Allen Hamilton Holding Corporation trades at $78.21 (market cap $9.45B). The key difference: Booz Allen Hamilton Holding Corporation is far larger — about 4.3× ADMA Biologics Inc's market cap, and Booz Allen Hamilton Holding Corporation pays a 3% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | BAH | |
|---|---|---|
Market Cap | $2.22B | $9.45B |
Sector | Health | Industrials |
52-Week High | $20.38 | $111.63 |
52-Week Low | $7.60 | $59.71 |
Enterprise Value | $2.29B | $13.07B |
Dividend Yield | — | 3% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.
Read more on BAH →
